Boston ScientificMEX:BSX -2.32%85 Current Ratio is 1.90 as of Mar. 2026, which is 41% above its 10-year median of 1.35. GuruFocus rates MEX:BSX with a GF Score™ of 85/100 and a GF Value™ of MXN1,840.77 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 854 Medical Devices & Instruments companies, Boston Scientific ranks worse than 63.47% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Boston Scientific's current ratio for the quarter that ended in Mar. 2026 was 1.90.
Boston Scientific has a current ratio of 1.90. It generally indicates good short-term financial strength.
The historical rank and industry rank for Boston Scientific's Current Ratio or its related term are showing as below:
MEX:BSX'
s Current Ratio Range Over the Past 10 Years
Min: 0.68 Med: 1.35 Max: 1.9
Current: 1.9
During the past 13 years, Boston Scientific's highest Current Ratio was 1.90. The lowest was 0.68. And the median was 1.35.
MEX:BSX's Current Ratio is ranked worse than 63.47% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 2.475
vs MEX:BSX: 1.90
Boston Scientific (MEX:BSX) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Boston Scientific Current Ratio Related Terms
Boston Scientific Current Ratio Historical Data
* Premium members only.
The historical data trend for Boston Scientific's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:BSX vs EW, GEHC, MDT: Current Ratio Comparison
For the Medical Devices subindustry, Boston Scientific's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Current Ratio distribution charts can be found below:
* The bar in red indicates where Boston Scientific's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (MEX:BSX) has a Current Ratio of 1.90 as of Mar. 2026. This is 41% above median its historical median of 1.35. Over the past decade, Boston Scientific's Current Ratio has ranged from 0.68 to 1.90. According to the industry distribution chart, Boston Scientific ranks #542 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 63.5%.
Is Boston Scientific's Current Ratio too high?
Boston Scientific's current Current Ratio of 1.90 is 41% above median its 10-year median of 1.35. Over the past 10 years, this metric has ranged from a low of 0.68 to a high of 1.90. The Medical Devices & Instruments industry median Current Ratio is 2.48. Boston Scientific's value of 1.90 is 23.2% below this industry median. Based on the distribution chart, Boston Scientific ranks #542 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Boston Scientific has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Current Ratio compare to EW and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Boston Scientific ranks #542 out of 854 companies for Current Ratio. This places Boston Scientific in the lower half of its industry. The industry median Current Ratio is 2.48. Boston Scientific's value of 1.90 is 23.2% below this benchmark. Historically, Boston Scientific's own Current Ratio has ranged from 0.68 to 1.90 over the past decade. While the company's 10-year median is 1.35 vs. the industry median of 2.48, Boston Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.48, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Boston Scientific's current Current Ratio of 1.90 is 23.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Boston Scientific's current Current Ratio is 1.90, which is 41% above median its own 10-year median of 1.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,840.77, compared to a current price of MXN759.00 — trading 58.8% below its estimated fair value. The current Current Ratio is 1.90, which is 41% above median its 10-year median of 1.35 and 23.2% below the Medical Devices & Instruments industry median of 2.48. Boston Scientific's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current Current Ratio is 1.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Boston Scientific (MEX:BSX) Overvalued in 2026?
Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued.
The current stock price of MXN759.00 is trading 58.8% below its estimated GF Value™ of MXN1,840.77.
GuruFocus considers Boston Scientific to be Significantly Undervalued.
Key valuation signals for MEX:BSX:
Current Ratio: 1.90 (41% above median its 10-year median of 1.35)
GF Value™: MXN1,840.77 vs. price of MXN759.00 (58.8% below fair value)
Industry Position: 23.2% below the Medical Devices & Instruments median (#542 of 854)
No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
85GF Score
Get the complete analysis for MEX:BSX
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:BSX has been successfully added to your 
